| |
| |
|
| Insider
Information: |
White William Richard |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
49,630 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,630 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-03-13 |
49,630 |
2019-12-31 |
0 |
Premium* |
|
|
Ventyx Biosciences, Inc. |
VTYX |
Director |
2023-01-23 |
0 |
2023-01-23 |
0 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
|
2024-05-01 |
0 |
2023-12-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-12-31 |
4 |
A |
$18.87 |
$19,338 |
D/D |
1,025 |
1,025 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-06-30 |
4 |
A |
$17.07 |
$21,250 |
D/D |
1,245 |
2,270 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-06-30 |
4 |
A |
$8.03 |
$9,251 |
D/D |
1,152 |
4,429 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,195 |
23,624 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
32,497 |
50,965 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-03 |
4 |
AS |
$30.56 |
$128,352 |
D/D |
(4,200) |
2,270 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-07-06 |
4 |
AS |
$24.52 |
$159,380 |
D/D |
(6,500) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-08-02 |
4 |
AS |
$22.03 |
$97,835 |
D/D |
(4,441) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-01 |
4 |
AS |
$24.00 |
$205,416 |
D/D |
(8,559) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-10-01 |
4 |
AS |
$22.06 |
$143,367 |
D/D |
(6,500) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-11-01 |
4 |
AS |
$22.24 |
$144,560 |
D/D |
(6,500) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-17 |
4 |
AS |
$22.04 |
$70,528 |
D/D |
(3,200) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-21 |
4 |
AS |
$22.00 |
$2,200 |
D/D |
(100) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-14 |
4 |
AS |
$22.03 |
$213,691 |
D/D |
(9,700) |
3,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-09-13 |
4 |
AS |
$26.42 |
$878,341 |
D/D |
(32,500) |
4,429 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-10-13 |
4 |
AS |
$39.82 |
$796,400 |
D/D |
(20,000) |
4,429 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-27 |
4 |
AS |
$49.77 |
$945,609 |
D/D |
(19,001) |
23,624 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-28 |
4 |
AS |
$49.76 |
$49,714 |
D/D |
(999) |
23,624 |
0 |
- |
|
| VTYX |
Ventyx Biosciences, Inc. |
Director |
– • – |
2023-01-23 |
4 |
AS |
$34.33 |
$1,170,592 |
D/D |
(33,353) |
0 |
0 |
% |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-13 |
4 |
AS |
$55.16 |
$33,427 |
D/D |
(606) |
22,377 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-09-13 |
4 |
AS |
$50.34 |
$31,815 |
D/D |
(632) |
18,468 |
0 |
- |
|
| IRON |
Disc Medicine, Inc |
|
– • – |
2024-04-11 |
4 |
AS |
$31.79 |
$81,407 |
D/D |
(2,560) |
0 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
|
– • – |
2024-05-01 |
4 |
AS |
$28.52 |
$5,755 |
D/D |
(201) |
0 |
0 |
% |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-03-10 |
4 |
D |
$43.47 |
$27,864 |
D/D |
(641) |
22,983 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-03 |
4 |
OE |
$7.01 |
$29,438 |
D/D |
4,200 |
6,470 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
